Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Downgrades Sio Gene Therapies to Sell

HC Wainwright & Co. analyst Joseph Pantginis downgrades Sio Gene Therapies (NASDAQ:SIOX) from Buy to Sell.
byBenzinga Newsdesk
April 28, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Joseph Pantginis downgrades Sio Gene Therapies (NASDAQ:SIOX) from Buy to Sell.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts